Hanying Bao - Concepedia

Author

Hanying Bao

Zhejiang University ORCID

Also Known As

H Bao, H. Bao, H. Y. Bao, Han-Ying Bao, Hanying Bao, Hao-Lin Bao, Haoyue Bao, Huanyu Bao, Huijie BAO, Huiyun Bao

Publications

401

Citations

H-Index

Concepts

All Affiliations

Zhejiang University First Affiliated Hospital Zhejiang University The University of Texas MD Anderson Cancer Center Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College

About

Hanying Bao is an author at Zhejiang University specializing in medicine, cell biology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	150
2	Cell Biology	2	2	138
3	Cellular Therapies	1	1	40
4	Immunology	1	1	40
5	Marrow Transplantation	1	1	40

Hanying Bao

Publications

302

Citations

H-Index

Page 1

	Year	Citations
Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways Haibo Mou, Yi Zheng, Peng Zhao, Toxicology in Vitro MitophagyMitochondrial FunctionMedicineApoptosisAutophagy	2011	98
Immune evasion of mantle cell lymphoma: expression of B7-H1 leads to inhibited T-cell response to and killing of tumor cells Linlin Wang, Jinfu Qian, Yue Lu, Haematologica	2013	64
TLR4 inactivation protects from graft-versus-host disease after allogeneic hematopoietic stem cell transplantation Yi Zhao, Qiuyan Liu, Yang Li, Cellular and Molecular Immunology Cell TherapyGraft-versus-host DiseaseTransplantationMarrow TransplantationAutoimmune Disease	2012	40
Triggering of toll-like receptor-4 in human multiple myeloma cells promotes proliferation and alters cell responses to immune and chemotherapy drug attack Hanying Bao, Peilin Lu, Yi Li, Cancer Biology & Therapy	2011	36
The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial Tingyu Wang, Xiuhua Sun, Lihua Qiu, Clinical Cancer Research	2023	32
Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer Nong Xu, Peng Shen, X. C. Zhang, Cancer Chemotherapy and Pharmacology Phase Ii TrialMedicinePharmacologyBronchial Neoplasm2-H Infusion	2006	12
[Polymorphisms of UGT1A gene and irinotecan toxicity in Chinese colorectal cancer patients]. Yan Wang, Jianming Xu, Lin Shen, PubMed	2007	10
A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell Lymphoma Jie Jin, Hong Cen, Keshu Zhou, Clinical Cancer Research	2024	10

Page 1